Prosper Junior Bakiny
TMFPBakiny
Prosper Junior Bakiny is a contributing Motley Fool healthcare analyst covering biotechnology, pharmaceuticals, and healthcare stocks. Before The Motley Fool, Prosper wrote about investing topics ranging from stock market news to private equity for various companies. He holds a master’s degree in corporate finance from the University of Maryland Global Campus.
Recent Articles by Prosper Junior Bakiny
Jan 17, 2025
by Prosper Junior Bakiny
Can Teladoc Stock Bounce Back in 2025?
Jan 13, 2025
by Prosper Junior Bakiny
2 Beaten-Down Dividend Stocks to Buy in 2025
Jan 4, 2025
by Prosper Junior Bakiny
Better Buy: Novo Nordisk vs. AstraZeneca
Dec 27, 2024
by Prosper Junior Bakiny
2 Brilliant Stocks to Buy and Hold for 10 Years
Dec 23, 2024
by Prosper Junior Bakiny
2 Excellent Dividend Stocks to Buy on the Dip
Dec 22, 2024
by Prosper Junior Bakiny
Is AstraZeneca Stock a Buy?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.